Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies-Reference-Cited by-同舟云学术

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

Published:2024-03 Issue:2 Volume:91 Page:105671
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Lauper Kim^ORCID,Mongin Denis^ORCID,Bergstra Sytske Anne^ORCID,Choquette Denis,Codreanu Catalin,Gottenberg Jacques-Eric,Kubo Satoshi^ORCID,Hetland Merete Lund^ORCID,Iannone Florenzo,Kristianslund Eirik K.^ORCID,Kvien Tore K.,Lukina Galina^ORCID,Mariette Xavier,Nordström Dan C.,Pavelka Karel,Pombo-Suarez Manuel,Rotar Ziga,Santos Maria J.^ORCID,Tanaka Yoshiya^ORCID,Turesson Carl^ORCID,Courvoisier Delphine S.^ORCID,Finckh Axel,Gabay Cem

Funder

Bristol-Myers Squibb

Roche

Publisher

Elsevier BV

Subject

Rheumatology

Reference36 articles.

1. Effects of cortisone acetate and pituitray ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions;Hench;Arch Intern Med,1950

2. Dose-related patterns of glucocorticoid-induced side effects;Huscher;Ann Rheum Dis,2009

3. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events;Saag;Am J Med,1994

4. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis;Hoes;Ann Rheum Dis,2009

5. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study;Dixon;Ann Rheum Dis,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small secret of big rheumatology;Rheumatology Science and Practice;2024-08-30

2. Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice;Terapevticheskii arkhiv;2024-06-03